Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine XR adjunctive therapy versus placebo for subsyndromal symptoms in bipolar disorder
2009-018195-33Phase 3Completed
- Sponsor
- Centro de Investigación Biomédica en Red de Salud Mental
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar disorder (BD) comparing Quetiapine XR adjunctive therapy with Placebo adjunctive therapy (2 arms). Primary endpoint: Change in MADRS total score from baseline to week 6. Started Feb 2010; status: completed.
02
Drugs
quetiapine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on 2009-018195-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018195-33.